Chester County News and Community Website
AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) reported a double-digit top-line increase and higher profitability for the quarter ended September 30, 2025, citing U.S. spine momentum, better margins, and …
Globus Medical Delivers Strong Q3 Growth, Raises Full-Year 2025 Guidance Read More AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) has unveiled the ANTHEM™ Elbow Fracture System, a comprehensive plating platform designed to simplify surgical workflows and expand treatment options for a …
Globus Medical Launches ANTHEM™ Elbow Fracture System to Advance Trauma Care Read More AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) announced that a Delaware jury has ruled in its favor in a high-profile patent infringement case against Life Spine, Inc., awarding the …
Globus Medical Wins Patent Infringement Case Against Life Spine Read More AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) reported a strong second quarter with revenue and profit growth fueled by solid performance in its U.S. Spine business and momentum across its …
Globus Medical Delivers Strong Q2 Results, Reaffirms 2025 Outlook Read More AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) has announced a major leadership transition alongside preliminary second-quarter results that show continued momentum in its core spine and enabling technologies businesses.
Globus Medical Names Keith Pfeil as CEO, Posts Strong Q2 Sales Growth Read More AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) has announced the expansion of its surgical navigation capabilities with the introduction of the DuraPro™ oscillating system, an advanced addition to its …
Globus Medical Expands Surgical Navigation Portfolio With Advanced DuraPro Oscillating System Read More AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) announced that its Board of Directors has authorized a share repurchase program of up to $500 million of the company’s common stock.
Globus Medical Announces $500M Share Repurchase Program to Boost Shareholder Value Read More AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) has announced its financial results for the first quarter of 2025, reporting revenue of $598.1 million, a decline of 1.4% compared to …
Globus Medical Reports Q1 2025 Results, Maintains Growth Outlook Read More AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) has finalized its acquisition of Nevro Corp., a leading global medical device company specializing in treatments for chronic pain.
Globus Medical Completes Acquisition of Nevro Corp. Read More AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) has unveiled two groundbreaking additions to its anterior lumbar interbody fusion (ALIF) portfolio with the launch of the COHERE™ ALIF Spacer and Modulus™ …
Globus Medical Introduces Advanced Solutions for ALIF Surgery Read More